| 产品名称： | Streptomyces fradiae (Waksman and Curtis) Waksman and Henrici |
|---|---|
| 商品货号： | TS156044 |
| Strain Designations： | A252.8 |
| Application： | Produces 20-dihydro-20-deoxy-23-de(mycinosyloxy)tylosin Production of 20-dihydro-20-deoxy-23-de(mycinosyloxy)tylosin and derivatives |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 196: Yeast malt extract agar |
| Growth Conditions： | Temperature: 26.0°C |
| Name of Depositor： | Eli Lilly & Co. |
| U.S. Patent Number： | |
| References： | Wild GM. Process for producing 20-dihydro-20-deoxy-23-de(-mycinosyloxy) tylosin. US Patent 4,423,148 dated Dec 27 1983 Kirst HA, et al. Process for producing 20-dihydro-20-deoxy-23-demycinosyltylosin. US Patent 4,304,856 dated Dec 8 1981 Kirst HA, et al. 20-Dihydro-20-deoxy-23-demycinosyltylosin and process for its production. US Patent 4,419,508 dated Dec 6 1983 Wild GM. 20-Dihydro-20-deoxy-23-de(mycinosyloxy)tylosin. US Patent 4,528,369 dated Jul 9 1985 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Streptomyces fradiae (Waksman and Curtis) Waksman and Henrici |
|---|---|
| 商品货号： | TS156044 |
| Strain Designations： | A252.8 |
| Application： | Produces 20-dihydro-20-deoxy-23-de(mycinosyloxy)tylosin Production of 20-dihydro-20-deoxy-23-de(mycinosyloxy)tylosin and derivatives |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 196: Yeast malt extract agar |
| Growth Conditions： | Temperature: 26.0°C |
| Name of Depositor： | Eli Lilly & Co. |
| U.S. Patent Number： | |
| References： | Wild GM. Process for producing 20-dihydro-20-deoxy-23-de(-mycinosyloxy) tylosin. US Patent 4,423,148 dated Dec 27 1983 Kirst HA, et al. Process for producing 20-dihydro-20-deoxy-23-demycinosyltylosin. US Patent 4,304,856 dated Dec 8 1981 Kirst HA, et al. 20-Dihydro-20-deoxy-23-demycinosyltylosin and process for its production. US Patent 4,419,508 dated Dec 6 1983 Wild GM. 20-Dihydro-20-deoxy-23-de(mycinosyloxy)tylosin. US Patent 4,528,369 dated Jul 9 1985 |
